Tubridge™: The Breakthrough Aneurism Medical Device

Chicago, the US – 17 June, 2015 - Tubridge™ Vascular Reconstruction Device ("Tubridge™"), a product of MicroPort NeuroTech (Shanghai) Co ("MicroPort NeuroTech"), recently drew wide attention in World Live Neurovascular Conference in Chicago. In a micro-surgery procedure to treat cerebral aneurysm live broadcasted in the congress, Tubridge™ was precisely inserted into the brain and successfully helped control blood flow into the aneurysm. The whole procedure lasted for 30 minutes and was highly recognized and praised by experts in attendance.
 
"In our clinical tests, we've shown that the cure rate for larger aneurysm is higher than 90%. It produces much better results than the traditional treatment," said Jianmin Liu from Shanghai Changhai Hospital, who completed the Tubridge™ procedure.
 
Tubridge™, which took eight years for Shanghai Changhai Hospital and MicroPort NeuroTech to jointly develop, marks a breakthrough in the treatment of cerebral aneurysm, as it is expected to reduce recurrence rates from 90% to lower than 5%. The device can successfully reconstruct cerebrovascular and also features excellent delivery ability, low collateral impact and high vessel patency rate.
 
A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons up and fills with blood. It is the main cause of subarachnoid hemorrhage. The bulging aneurysm can put pressure on a nerve or surrounding brain tissue. Aneurysms can later burst and bleed into the brain, causing serious complications or even death. Larger aneurysms are the most dangerous, with high aneurysmal rupture rate, high treatment cost, complex operating procedure and high recurrence rate.